Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

MicroRNAs and Congenital Heart Disease: Where Are We Now?

Pulignani S, Andreassi MG.

Rev Esp Cardiol (Engl Ed). 2019 Jan;72(1):7-9. doi: 10.1016/j.rec.2018.06.030. Epub 2018 Jul 25. English, Spanish. No abstract available.

PMID:
30056121
2.

Prognostic value of mitochondrial DNA4977 deletion and mitochondrial DNA copy number in patients with stable coronary artery disease.

Vecoli C, Borghini A, Pulignani S, Mercuri A, Turchi S, Carpeggiani C, Picano E, Andreassi MG.

Atherosclerosis. 2018 Sep;276:91-97. doi: 10.1016/j.atherosclerosis.2018.07.015. Epub 2018 Jul 25.

PMID:
30053637
3.

Altered DNA methylation indicates an oscillatory flow mediated epithelial-to-mesenchymal transition signature in ascending aorta of patients with bicuspid aortic valve.

Björck HM, Du L, Pulignani S, Paloschi V, Lundströmer K, Kostina AS, Österholm C, Malashicheva A, Kostareva A, Evangelista A, Teixidó-Tura G, Maleki S, Franco-Cereceda A, Eriksson P; Mechanistic Interrogation of Bicuspid Aortic Valve associated Aortopathy (MIBAVA) Leducq Consortium.

Sci Rep. 2018 Feb 9;8(1):2777. doi: 10.1038/s41598-018-20642-4.

4.

Targeted Next-Generation Sequencing in Patients with Non-syndromic Congenital Heart Disease.

Pulignani S, Vecoli C, Borghini A, Foffa I, Ait-Alì L, Andreassi MG.

Pediatr Cardiol. 2018 Apr;39(4):682-689. doi: 10.1007/s00246-018-1806-y. Epub 2018 Jan 13.

PMID:
29332214
5.

A Functional Aryl Hydrocarbon Receptor Genetic Variant, Alone and in Combination with Parental Exposure, is a Risk Factor for Congenital Heart Disease.

Pulignani S, Borghini A, Vecoli C, Foffa I, Ait-Ali L, Andreassi MG.

Cardiovasc Toxicol. 2018 Jun;18(3):261-267. doi: 10.1007/s12012-017-9436-9.

PMID:
29185192
6.

miRNome Profiling in Bicuspid Aortic Valve-Associated Aortopathy by Next-Generation Sequencing.

Borghini A, Foffa I, Pulignani S, Vecoli C, Ait-Ali L, Andreassi MG.

Int J Mol Sci. 2017 Nov 22;18(11). pii: E2498. doi: 10.3390/ijms18112498.

7.

Genetic and Epigenetic Mechanisms Linking Air Pollution and Congenital Heart Disease.

Vecoli C, Pulignani S, Andreassi MG.

J Cardiovasc Dev Dis. 2016 Nov 29;3(4). pii: E32. doi: 10.3390/jcdd3040032. Review.

8.

Radiobiological Effectiveness of Ultrashort Laser-Driven Electron Bunches: Micronucleus Frequency, Telomere Shortening and Cell Viability.

Andreassi MG, Borghini A, Pulignani S, Baffigi F, Fulgentini L, Koester P, Cresci M, Vecoli C, Lamia D, Russo G, Panetta D, Tripodi M, Gizzi LA, Labate L.

Radiat Res. 2016 Sep;186(3):245-53. doi: 10.1667/RR14266.1. Epub 2016 Jul 19.

PMID:
27439449
9.

3'UTR SNPs and Haplotypes in the GATA4 Gene Contribute to the Genetic Risk of Congenital Heart Disease.

Pulignani S, Vecoli C, Sabina S, Foffa I, Ait-Ali L, Andreassi MG.

Rev Esp Cardiol (Engl Ed). 2016 Aug;69(8):760-5. doi: 10.1016/j.rec.2016.03.004. Epub 2016 Apr 23. English, Spanish.

PMID:
27118528
10.

Congenital heart disease: the crossroads of genetics, epigenetics and environment.

Vecoli C, Pulignani S, Foffa I, Andreassi MG.

Curr Genomics. 2014 Oct;15(5):390-9. doi: 10.2174/1389202915666140716175634.

11.

Holt-Oram syndrome with intermediate atrioventricular canal defect, and aortic coarctation: functional characterization of a de novo TBX5 mutation.

Baban A, Pitto L, Pulignani S, Cresci M, Mariani L, Gambacciani C, Digilio MC, Pongiglione G, Albanese S.

Am J Med Genet A. 2014 Jun;164A(6):1419-24. doi: 10.1002/ajmg.a.36459. Epub 2014 Mar 24.

PMID:
24664498
12.

Germline hereditary, somatic mutations and microRNAs targeting-SNPs in congenital heart defects.

Sabina S, Pulignani S, Rizzo M, Cresci M, Vecoli C, Foffa I, Ait-Ali L, Pitto L, Andreassi MG.

J Mol Cell Cardiol. 2013 Jul;60:84-9. doi: 10.1016/j.yjmcc.2013.04.002. Epub 2013 Apr 11.

PMID:
23583740
13.

Lack of association of the 3'-UTR polymorphism (rs1017) in the ISL1 gene and risk of congenital heart disease in the white population.

Cresci M, Vecoli C, Foffa I, Pulignani S, Ait-Ali L, Andreassi MG.

Pediatr Cardiol. 2013 Apr;34(4):938-41. doi: 10.1007/s00246-012-0578-z. Epub 2012 Nov 15.

PMID:
23229290
14.

Genetics of congenital heart defects: is it not all in the DNA?

Pulignani S, Cresci M, Andreassi MG.

Transl Res. 2013 Jan;161(1):59-61. doi: 10.1016/j.trsl.2012.07.003. Epub 2012 Aug 10. No abstract available.

PMID:
22885174
15.

Maternal environmental exposure, infant GSTP1 polymorphism, and risk of isolated congenital heart disease.

Cresci M, Foffa I, Ait-Ali L, Pulignani S, Kemeny A, Gianicolo EA, Andreassi MG.

Pediatr Cardiol. 2013 Feb;34(2):281-5. doi: 10.1007/s00246-012-0436-z. Epub 2012 Jul 20.

PMID:
22815093
16.

Maternal and paternal environmental risk factors, metabolizing GSTM1 and GSTT1 polymorphisms, and congenital heart disease.

Cresci M, Foffa I, Ait-Ali L, Pulignani S, Gianicolo EA, Botto N, Picano E, Andreassi MG.

Am J Cardiol. 2011 Dec 1;108(11):1625-31. doi: 10.1016/j.amjcard.2011.07.022. Epub 2011 Sep 3.

PMID:
21890078
17.

[Genetic screening of Gata4 and Nkx2.5 mutations in hereditary congenital heart defects: 5 familial cases].

Pulignani S, Foffa I, Cresci M, Vittorini S, Ait-Ali L, Andreassi MG.

Recenti Prog Med. 2011 Mar;102(3):120-5. doi: 10.1701/608.7068. Italian.

PMID:
21572484
18.

[A novel lamin A/C mutation in a family with dilated cardiomyopathy and a strong history of sudden cardiac death].

Andreassi MG, Botto N, Vittorini S, Pulignani S, Aquaro G, Sicari R.

Recenti Prog Med. 2010 Mar;101(3):127-30. Italian.

PMID:
20461955

Supplemental Content

Loading ...
Support Center